Zantac Lawsuit
If you or a loved one took Zantac for heartburn and were diagnosed with cancer, you may be entitled to significant compensation. The FDA recalled all Zantac products in April 2020 due to dangerous NDMA contamination. Time is limited to file.
Get A Free Case ReviewATTENTION: ZANTAC USERS
If you took Zantac and were diagnosed with cancer, you could be entitled to SIGNIFICANT compensation. Time is limited to file!
Zantac (Ranitidine) was found to contain NDMA — a probable human carcinogen. The FDA recalled all Zantac products in April 2020. Studies have linked long-term NDMA exposure to multiple cancers.
Find Out if You Qualify
SIGNIFICANT Compensation May Be Available
LARGE SETTLEMENT AMOUNT
COULD BE CLAIMED
How do we help YOU?
Zantac (Ranitidine) was found to contain NDMA — a probable human carcinogen. The FDA recalled all prescription and OTC Zantac products in April 2020. Studies have linked long-term NDMA exposure to multiple cancers. If you took Zantac and were later diagnosed with cancer, time is limited to file your claim.
How does filing a claim work?
- 1. Fill out our simple form. Or call to make your claim immediately.
- 2. Get a FREE case review from our expert partners.
- 3. We fight on your behalf for the highest compensation possible.
- 4. Claim your settlement!
- Remember: you only pay if you get a settlement! Our service is totally RISK FREE.
Zantac was found to contain NDMA — a probable human carcinogen — and was recalled by the FDA in April 2020.
NDMA (N-Nitrosodimethylamine) is inherently unstable and can form and increase over time in Ranitidine products, especially at higher temperatures. Long-term exposure to NDMA has been linked to the development of multiple forms of cancer. Manufacturers are accused of knowing about this contamination risk and failing to warn consumers.
What Is the Zantac Lawsuit?
Zantac (Ranitidine), once one of the world's best-selling heartburn medications, was found to contain dangerous levels of NDMA — a probable human carcinogen. The FDA recalled all prescription and OTC Zantac products in April 2020.
Lawsuits allege manufacturers knew or should have known about NDMA contamination and failed to warn consumers — leaving millions of patients exposed to a cancer-causing substance without any warning.
Who Qualifies for a Zantac Lawsuit?
Individuals who regularly took Zantac or Ranitidine and were subsequently diagnosed with bladder, breast, colon, esophageal, kidney, liver, pancreatic, prostate, or stomach cancer may be eligible to file a claim.
Did Zantac contribute to your cancer diagnosis?
Get A Free Case ReviewCancers Linked to Zantac (NDMA)
- Bladder Cancer
- Breast Cancer
- Colorectal / Colon Cancer
- Esophageal Cancer
- Kidney Cancer
- Liver Cancer
- Pancreatic Cancer
- Prostate Cancer
- Stomach Cancer
What Is NDMA and Why Is It Dangerous?
NDMA (N-Nitrosodimethylamine) is a probable human carcinogen found in Zantac's active ingredient, Ranitidine. The chemical is inherently unstable and can form and increase over time, especially under higher temperatures during storage or shipping.
Long-term exposure to NDMA has been linked to the development of multiple forms of cancer. Despite this, manufacturers are accused of failing to adequately warn consumers about the risk of NDMA contamination in their products.
Zantac Lawsuit Timeline and Settlements
The FDA issued its recall of Zantac in April 2020. Litigation is ongoing across state and federal courts. Settlement amounts depend on cancer diagnosis type, severity, duration of Zantac use, and other health impacts.
Filing deadlines apply — contact a legal expert promptly to ensure your claim is filed in time.